Armodafinil



Armodafinil





(are moe daff’ ih nill)

Nuvigil

PREGNANCY CATEGORY C

CONTROLLED SUBSTANCE C-IV


Drug Classes

CNS stimulant

Narcolepsy drug


Therapeutic Actions

A CNS stimulant that helps to improve vigilance and decrease excessive daytime sleepiness associated with narcolepsy and other sleep disorders. May act through dopaminergic mechanisms; exact mechanism of action is not known. Not associated with the cardiac and other systemic stimulatory effects of amphetamines.


Indications



  • To improve wakefulness in patients with excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome, narcolepsy, and shift work sleep disorder



Available Forms

Tablets—50, 150, 250 mg


Dosages

Adults



  • Obstructive sleep apnea/hypopnea syndrome, narcolepsy: 150–250 mg/day PO as a single dose in the morning.


  • Shift work sleep disorder: 150 mg/day PO taken 1 hr before start of work shift.

Patients with severe hepatic impairment, elderly patients

Consider use of a lower dose.



Pharmacokinetics















Route Onset Peak
Oral Rapid 2 hr

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 20, 2016 | Posted by in NURSING | Comments Off on Armodafinil

Full access? Get Clinical Tree

Get Clinical Tree app for offline access